The Global Small Molecule (API) Industry is on the brink of unprecedented growth, with forecasts indicating a substantial increase from US$ 116 billion in 2023 to an estimated US$ 174 billion by 2033. This remarkable trajectory reflects a Compound Annual Growth Rate (CAGR) of 4.1% over the forecast period. As a cornerstone of the pharmaceutical …